Literature DB >> 14707293

Contribution of cerebral amyloid angiopathy to Alzheimer's disease.

S Love.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14707293      PMCID： PMC1757461          DOI： 10.1136/jnnp.2003.034249

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  14 in total

1.  Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.

Authors:  H K Lückhoff; M Kidd; S J van Rensburg; D P van Velden; M J Kotze
Journal:  Metab Brain Dis       Date:  2016-02       Impact factor: 3.584

2.  The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.

Authors:  E Kövari; F R Herrmann; P R Hof; C Bouras
Journal:  Neuropathol Appl Neurobiol       Date:  2013-08       Impact factor: 8.090

3.  ACE variants and association with brain Aβ levels in Alzheimer's disease.

Authors:  J Scott Miners; Zoë van Helmond; Merryn Raiker; Seth Love; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2010-10-15       Impact factor: 4.060

4.  Clinical, laboratory, and radiological features of cerebral amyloid angiopathy-related inflammation (CAA-ri): retrospective, observational experience of a single centre.

Authors:  Dan Li; Weiwei Qin; Yang Guo; Mingrong Xia; Siyuan Li; Jiewen Zhang; Weizhou Zang
Journal:  Neurol Sci       Date:  2022-10-07       Impact factor: 3.830

5.  Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.

Authors:  Rachel Barker; Dannielle Wellington; Margaret M Esiri; Seth Love
Journal:  J Cereb Blood Flow Metab       Date:  2013-03-27       Impact factor: 6.200

Review 6.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Blas Frangione; Agueda Rostagno; Jorge Ghiso
Journal:  Acta Neuropathol       Date:  2009-02-19       Impact factor: 17.088

7.  Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  Jonathan Graff-Radford; Jeannette Simino; Kejal Kantarci; Thomas H Mosley; Michael E Griswold; B Gwen Windham; A Richey Sharrett; Marilyn S Albert; Rebecca F Gottesman; Clifford R Jack; Prashanthi Vemuri; David S Knopman
Journal:  Stroke       Date:  2017-10-10       Impact factor: 7.914

8.  Changes in the Chemical Barrier Composition of Tears in Alzheimer's Disease Reveal Potential Tear Diagnostic Biomarkers.

Authors:  Gergő Kalló; Miklós Emri; Zsófia Varga; Bernadett Ujhelyi; József Tőzsér; Adrienne Csutak; Éva Csősz
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

Review 9.  Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease.

Authors:  Sang-Sun Yoon; Sangmee Ahn Jo
Journal:  Biomol Ther (Seoul)       Date:  2012-05       Impact factor: 4.634

Review 10.  Mechanisms of Aβ Clearance and Degradation by Glial Cells.

Authors:  Miriam Ries; Magdalena Sastre
Journal:  Front Aging Neurosci       Date:  2016-07-05       Impact factor: 5.750
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.